New drug LY3867070 put to the test in healthy humans

NCT ID NCT07021547

Recruiting now Knowledge-focused Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage study is testing an experimental oral drug called LY3867070 in 196 healthy volunteers. The main goal is to see if the drug is safe and what side effects it might cause. Researchers will also measure how the body processes the drug. This is a first step to see if the drug can be studied further for possible medical use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LY3867070 (an experimental oral drug)
What could go wrong: This is a very early Phase 1 study in healthy people, so it cannot show if the drug works for any disease. The main goal is just safety and dosing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Anaheim Clinical Trials, LLC
RECRUITING

Anaheim, California, 92801, United States

Contact Phone: •••-•••-••••

Contact
Fortrea Clinical Research Unit
RECRUITING

Dallas, Texas, 75247, United States

Contact Phone: •••-•••-••••

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.